T2 Biosystems CS (TTOO)

$0.26 0.00 (N/A)
Market Cap 5.47M
Revenue (ttm) 7.19M
Net Income (ttm) -50.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -696.52%
Debt to Equity Ratio 0.00
Volume 917,000
Avg Vol 924,868
Day's Range N/A - N/A
Shares Out 21.04M
Stochastic %K 6%
Beta 0.40
Analysts Hold
Price Target $5.00

Latest News on TTOO

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

Dec 16, 2024, 9:00 AM EST - 4 weeks ago

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Dec 9, 2024, 9:00 AM EST - 5 weeks ago

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 6:12 PM EST - 2 months ago

T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

Nov 5, 2024, 8:00 AM EST - 2 months ago

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript

Oct 10, 2024, 8:27 PM EDT - 3 months ago

T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript

T2 Biosystems to Host Business Update Call on October 10, 2024

Oct 8, 2024, 4:05 PM EDT - 3 months ago

T2 Biosystems to Host Business Update Call on October 10, 2024

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

Oct 7, 2024, 9:05 AM EDT - 3 months ago

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union

Sep 20, 2024, 9:00 AM EDT - 4 months ago

T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union

T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 4:05 PM EDT - 5 months ago

T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

T2 Biosystems to Attend Upcoming Investor Conferences

Aug 1, 2024, 4:05 PM EDT - 6 months ago

T2 Biosystems to Attend Upcoming Investor Conferences

T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 6:36 PM EDT - 6 months ago

T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript

T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor

Jul 29, 2024, 4:02 PM EDT - 6 months ago

T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor

T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024

Jul 22, 2024, 4:05 PM EDT - 6 months ago

T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024

T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements

May 22, 2024, 9:00 AM EDT - 8 months ago

T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements

T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

May 17, 2024, 4:05 PM EDT - 8 months ago

T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

May 15, 2024, 7:00 AM EDT - 8 months ago

T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock

May 14, 2024, 5:00 PM EDT - 8 months ago

T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock

T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

May 7, 2024, 9:00 AM EDT - 9 months ago

T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript

May 6, 2024, 11:43 PM EDT - 9 months ago

T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript

T2 Biosystems Announces Commercial Expansion Through Middle East Distributor

May 6, 2024, 4:34 PM EDT - 9 months ago

T2 Biosystems Announces Commercial Expansion Through Middle East Distributor

T2 Biosystems Announces First Quarter 2024 Financial Results

May 6, 2024, 4:34 PM EDT - 9 months ago

T2 Biosystems Announces First Quarter 2024 Financial Results

T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity

May 6, 2024, 4:29 PM EDT - 9 months ago

T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

Apr 24, 2024, 9:00 AM EDT - 9 months ago

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity

Apr 11, 2024, 4:05 PM EDT - 10 months ago

T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity

T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates

Mar 20, 2024, 7:30 AM EDT - 10 months ago

T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates

T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates

Mar 19, 2024, 9:00 AM EDT - 10 months ago

T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates

T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel

Mar 18, 2024, 9:00 AM EDT - 10 months ago

T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel

T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement

Mar 12, 2024, 9:00 AM EDT - 11 months ago

T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement

T2 Biosystems (TTOO) share price stays stable post Q4 earnings

Feb 16, 2024, 11:09 AM EST - 1 year ago

T2 Biosystems (TTOO) share price stays stable post Q4 earnings

T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 7:37 PM EST - 1 year ago

T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024, 4:06 PM EST - 1 year ago

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results

T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity

Feb 15, 2024, 4:04 PM EST - 1 year ago

T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity

T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia

Feb 15, 2024, 4:02 PM EST - 1 year ago

T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia

T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel

Feb 12, 2024, 9:00 AM EST - 1 year ago

T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel

T2 BioSystems stock: brace for TTOO volatility this week

Feb 12, 2024, 6:34 AM EST - 1 year ago

T2 BioSystems stock: brace for TTOO volatility this week

T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024

U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize

Feb 7, 2024, 9:00 AM EST - 1 year ago

U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

Jan 18, 2024, 9:00 AM EST - 1 year ago

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing

Jan 3, 2024, 9:00 AM EST - 1 year ago

T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing

What's going on with T2 Biosystems (TTOO) stock?

Dec 20, 2023, 5:00 AM EST - 1 year ago

What's going on with T2 Biosystems (TTOO) stock?

T2 Biosystems (TTOO) stock price volatility has died: buy the dip?

Nov 13, 2023, 9:35 AM EST - 1 year ago

T2 Biosystems (TTOO) stock price volatility has died: buy the dip?

T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 3, 2023, 9:00 AM EDT - 1 year ago

T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

T2 Biosystems Regains Compliance with Nasdaq Listing Requirements

Nov 1, 2023, 9:00 AM EDT - 1 year ago

T2 Biosystems Regains Compliance with Nasdaq Listing Requirements

T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference

Oct 24, 2023, 4:05 PM EDT - 1 year ago

T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference

T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement

Oct 23, 2023, 9:00 AM EDT - 1 year ago

T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement

T2 Biosystems, Inc. (TTOO) Preliminary Q3 2023 Earnings Call Transcript

Oct 12, 2023, 7:50 PM EDT - 1 year ago

T2 Biosystems, Inc. (TTOO) Preliminary Q3 2023 Earnings Call Transcript

T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates

Oct 12, 2023, 4:05 PM EDT - 1 year ago

T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates

T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii

Oct 12, 2023, 4:02 PM EDT - 1 year ago

T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii

T2 Biosystems Announces Reverse Stock Split Effective Today

Oct 12, 2023, 9:00 AM EDT - 1 year ago

T2 Biosystems Announces Reverse Stock Split Effective Today

TTOO stock price: brace for T2 Biosystems volatility after earnings

Oct 11, 2023, 10:02 PM EDT - 1 year ago

TTOO stock price: brace for T2 Biosystems volatility after earnings